Atlas Dashboards
Screeners Create Scan, Old
Charts*new* Candlestick, P&F
Premium Realtime & Alerts
Login/Register Scans, Watchlists
Contact Us [email protected]

Par Drugs & Chemicals Ltd - Technical chart

consolidated in Rs/Cr.
Industry

Industry name

 Pharmaceuticals
Variance

Full Year Net Profit Variance

 -13
Equity

Latest Equity

 12.3
Face Value

Latest Face Value

 10
Reserves

Total Reserve

 99.68
Dividend

Full Year Dividend %

 0
Sales Turnover

Full Year Net Sales

 103.66
Net Profit

Full Year Net Profit

 10.5
Full Year CPS

Full Year Cash Per Share

 11.5
Earning Per Share

Full Year Earning Per Share

 8.5
Quarter CPS

Latest quarter Cash Per Share

 0
Latest Quarter Date

Latest Quarter Yrc

 Jun 1, 2026
Latest Quarter Sales

Latest Quarter Net Sales

 31.28
Previous EPS

Previous earnings per share

 0
Book Value

Book value

 91
Networth

Full Year Return on Networth

 9.95
Price/Book Value

Price to Book value

 1.43956
Yearly PE ratio

Full Year Price to Earning per share

15.4
Yearly PC ratio

Full Year Price to Cash Per Share

11.4
Bse value

BSE Value in lakhs

 0
Nse value

NSE Value in lakhs

 12.08
High

52 week high

 180
Low

52 week low

 78
Price

NSE Current market price

 131
CPM

Current market price

 0
Market cap

BSE / NSE Market Cap

 161.7
Net profit

Latest Quarter Net Profit

 4.71
Net profit variance

Latest Quarter Net Profit variance

42
Result year

Trailing latest month

 Jun 1, 2026
TTM Sales

Trailing Twelve 12 month Net Sales

0
TTM OP

Trailing Twelve 12 month Operating Profit

 0
TTM OPM

Trailing Twelve 12 month Operating Profit Margin

 0
TTM GP

Trailing Twelve 12 month Gross Profit

 22.92
TTM GPM

Trailing Twelve 12 month Gross Profit Margin

21.05
TTM NP

Trailing Twelve 12 month Net Profit

0
TTM NPV

Trailing Twelve 12 month Net Profit Variane

2.4
TTM EPS

Trailing Twelve 12 month EPS

 11.78
TTM PE

Trailing Twelve 12 month PE

 11.16
TTM CPS

Trailing Twelve 12 month CPS

 0
Month CPS

Month Cash Per Share

 0
TTM Depreciation

Trailing Twelve 12 month Depreciation

 0
Equity

Latest Equity

 12.3
LTP

Latest Price (BSE/NSE)

 131
Gross block

Latest Gross Block

 75.98
Loans

Total loans

 0
Advances

Latest Advances for Banks

 0
Net profit asset

Latest Assets

 0
Year OPM

Full Year Operating Profit Margin

14.5
Year GPM

Full Year Gross Profit Margin

 18.3
Quarter OPM

Latest quater Operation Profit Margin

20.4

Quarterly Results (consolidated, figures in Rs Cr.)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
+ Sales 35 21 22 26 29 29 20 31
YOY Sales Growth % 34% -11% -2% 15% -17% 37% -12% 20%
Gross Sales 35 21 22 26 29 29 20 31
+ Expenses 23 20 20 22 23 23 18 25
Material Cost % 28% 42% 50% 42% 36% 40% 45% 38%
Raw Material Cost 11 9 10 11 11 12 9 13
Change in Inventory -1 0 1 0 0 0 0 -1
Manufacturing Cost % 28% 46% 37% 37% 37% 32% 37% 30%
Employee Cost % 4% 6% 9% 5% 5% 5% 10% 5%
Other Cost % 7% -1% -6% 1% 1% 2% 1% 6%
Raw Materials % 31% 42% 47% 43% 37% 41% 45% 41%
Stock Adjustments % 4% -0% -3% 1% 1% 1% 0% 3%
Other Manufacturing Expenses % 28% 46% 37% 37% 37% 32% 37% 30%
Operating Profit 11 1 2 4 6 6 1 6
OPM % 33% 7% 11% 14% 21% 21% 7% 20%
+ Other Income 1 0 1 2 0 1 0 1
Miscellaneous Income 1 0 1 2 0 1 0 1
Interest 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 1
Profit before tax 11 1 2 4 6 6 1 6
+ Tax % 25% 25% 28% 26% 26% 25% -4% 26%
Current Tax 3 0 1 1 1 2 0 2
Deferred Tax 0 0 0 0 0 0 0 0
Net Profit 9 1 2 3 4 5 1 5
EPS in Rs

Profit & Loss (consolidated, figures in Rs Cr.)

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
+ Sales 49 42 53 56 69 85 96 107 113 116
Sales Growth % -13% 25% 5% 24% 23% 13% 12% 6% 3%
Gross Sales 61 75 96 96 101 104
Excise Duty 0 0 7 0 8 10 0 12 12 13
+ Expenses 37 34 38 43 55 69 78 84 94 99
Material Cost % 43% 42% 36% 42% 32% 34% 42% 32% 34% 37%
Raw Material Cost 20 18 19 22 22 30 41 33 39 43
Change in Inventory 1 0 0 1 0 -1 -1 0 -1 1
Manufacturing Cost % 29% 27% 25% 25% 19% 21% 24% 20% 22% 21%
Employee Cost % 4% 5% 7% 7% 6% 5% 5% 5% 5% 5%
Other Cost % 1% 7% 4% 3% 23% 21% 10% 22% 22% 21%
Raw Materials % 40% 42% 36% 40% 32% 35% 43% 31% 35% 37%
Stock Adjustments % -3% 0% 0% -3% 0% 1% 1% -0% 1% -1%
Power & Fuel % 17% 16% 17% 19% 14% 16% 19% 15% 17% 16%
Other Manufacturing Expenses % 11% 11% 8% 6% 5% 5% 5% 5% 5% 5%
Selling & Administration % 7% 7% 4% 8% 8% 10% 10% 9% 10% 10%
Miscellaneous Expenses % 0% 0% 0% 0% 0% 0% 0% 1% 0% 0%
Operating Profit 11 8 15 12 14 16 18 23 20 17
OPM % 23% 19% 28% 22% 20% 19% 19% 21% 17% 15%
+ Other Income 0 0 0 0 2 0 0 0 2 4
Miscellaneous Income 0 0 0 0 2 4
Interest 3 2 2 1 1 0 0 0 0 0
Depreciation 3 3 3 3 3 3 3 3 4 4
Profit before tax 13 13 15 20 18 17
+ Tax % 24% 27% 25% 26% 25% 24%
Current Tax 1 1 1 1 3 3 4 5 5 5
Deferred Tax 1 1 0 0 0 0 0 0 0 0
+ Net Profit 10 9 11 15 13 13
Profit Growth % -4% 23% 28% -8% -2%
EPS in Rs

Balance Sheet (consolidated, figures in Rs Cr.)

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 8 8 4 6 6 12 12 12 12 12
Reserves 11 12 25 34 46 48 59 73 87 100
+ Borrowings 25 23 12 6 8 0 0 0 0 0
Secured Borrowings 16 14 12 1 5 0 0 0 0 0
Unsecured Borrowings 9 10 0 5 4 0 0 0 0 0
Deferred Credit 1 1 0 0 0 0 0 0 0 0
+ Other Liabilities 12 10 11 14 16 19 18 16 20 17
Current Liabilities 13 10 10 13 16 19 18 16 20 17
Provisions 1 1 1 2 4 3 4 5 5 5
Other liability items 0 0 0 0 0 0 0 0 0 0
Total Liabilities 56 54 51 60 76 79 89 102 119 129
+ Fixed Assets 42 39 36 34 30 34 38 41 39 36
Gross Block 56 56 57 57 53 60 68 74 75 76
Accumulated Depreciation 14 17 20 23 23 26 29 33 36 40
CWIP 0 0 0 1 5 0 0 0 0 1
Investments 0 0 0 0 0 0 0 0 25 27
+ Other Assets 14 15 15 25 42 44 50 60 55 65
Inventories 4 4 4 3 3 5 5 4 6 5
Trade receivables 8 9 9 12 12 18 17 14 17 12
Cash Equivalents 0 0 0 7 21 16 22 37 28 42
Loans n Advances 2 1 1 2 5 4 5 5 4 5
Other asset items 0 1 1 1 1 1 1 1 1 1
Total Assets 56 54 51 60 76 79 89 102 119 129

Cash Flow (consolidated, figures in Rs Cr.)

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
+ Cash from Operating Activity 9 4 2 8 12 8 13 20 16 16
Profit Before Tax & Extraordinary Items 3 3 3 6 15 13 15 20 18 17
Depreciation 3 3 3 3 3 3 3 3 4 4
Interest (Net) 2 2 1 1 1 0 0 0 0 0
Dividend Received 0 0 0 0 0 0 0 0 0 0
Profit / Loss on Sale of Assets 0 0 0 0 -2 0 0 0 0 0
Profit / Loss on Sale of Investments 0 0 0 0 0 0 0 0 0 0
Provisions & Write-offs (Net) 0 0 0 0 0 0 0 0 0 0
Receivables -1 -1 0 -4 0 -6 2 3 -3 5
Inventories 2 0 0 1 0 -2 -1 1 -2 1
Trade Payables 1 -3 -4 1 1 4 -3 -3 6 -3
Loans & Advances 0 0 0 0 0 0 0 0 0 0
Direct Taxes Paid -1 0 -1 -1 -4 -3 -4 -4 -5 -5
+ Cash from Investing Activity -2 -1 0 -1 0 -3 -7 -6 -25 -2
Purchase of Fixed Assets -2 -1 0 -2 -5 -3 -8 -6 -1 -2
Sale of Fixed Assets 0 0 0 0 5 0 0 0 0 0
Purchase of Investments 0 0 0 0 0 0 0 0 -25 -2
Sale of Investments 0 0 0 0 0 0 0 0 0 0
Interest Received 0 0 0 0 0 0 0 0 0 0
Dividend Received 0 0 0 0 0 0 0 0 0 0
Others 0 0 0 0 0 0 0 0 1 2
+ Cash from Financing Activity -8 -4 -2 1 2 -10 0 0 0 0
Proceeds from Issue of Shares 0 0 6 9 0 0 0 0 0 0
Proceeds from Short-Term Borrowings 0 0 0 0 3 0 0 0 0 0
Repayment of Long-Term Borrowings -2 0 -7 -1 0 -4 0 0 0 0
Repayment of Short-Term Borrowings -3 -1 -1 -4 0 -3 0 0 0 0
Dividend Paid 0 0 0 -1 -1 -2 0 0 0 0
Others 0 0 0 0 0 0 0 0 0 0
Net Cash Flow -1 0 0 7 14 -5 6 14 -9 14